Luminal B breast cancer is a molecular subtype of breast cancer. Luminal B cells have estrogen and progesterone receptors. That means these hormones can cause cancer growth. Treatments for luminal B breast cancer include hormone therapy, targeted therapy and surgery. Outlook is more positive the earlier you treat it.
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Luminal B breast cancer is a subtype of hormone receptor-positive (HR+) breast cancer. Luminal B breast cancer cells have proteins (receptors) inside them that cause cancer to grow when the hormone estrogen attaches to them. The term “luminal” refers to cells in the inner lining of your breast ducts.
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Luminal B cancer cells are:
All these letters, numbers and abbreviations represent a molecular-level profile of the cancer cells in your breast. Healthcare providers use this information to develop personalized treatments and predict treatment outcomes.
Luminal B breast cancer makes up about 15% to 20% of all breast cancer cases. It’s less common than luminal A breast cancer.
Healthcare providers often detect luminal B breast cancer through screenings before symptoms develop. But if you do notice symptoms, they might include:
Advertisement
Luminal B breast cancer happens when healthy breast cells change and grow uncontrollably. But experts don’t know exactly why this happens.
Luminal B cells contain proteins that cause cancer growth when estrogen attaches to them. So, you have a slightly higher risk of developing luminal B if you started your period early, went through menopause later than expected or received HRT.
Other factors that might increase your risk for luminal B breast cancer include:
If you develop breast cancer symptoms or receive suspicious mammogram results, a healthcare provider will start with a physical exam. They’ll likely order additional imaging tests like a diagnostic mammogram, ultrasound or MRI.
Your healthcare provider will also do a breast biopsy. During this procedure, they’ll take a sample of your breast tissue and send it to a lab for analysis.
A pathologist will test your tissue sample for cancer cells. If they find cancer cells, they’ll run hormone receptor tests and HER2 tests to determine the cancer subtype. Among these tests, immunohistochemistry (a type of immunostaining) is the most common. It uses fluorescent dyes and enzymes to highlight specific molecules in your breast cells.
Running tests on your tissue sample can tell your healthcare team what type of treatments might work. It can also tell them how likely it is that cancer will return after treatment.
Other luminal B breast cancer treatments include:
Advertisement
Luminal B cancer treatment varies depending on your situation and lab test results. For example, someone with HER2+ breast cancer will need a different treatment than someone with HER2- breast cancer.
You can’t change certain risk factors, like family history. But doing these things might reduce your risk for luminal B breast cancer:
The prognosis for people with luminal B breast cancer depends on how advanced the tumor is at the time of diagnosis. Like most cancers, the sooner you begin treatment, the better your outlook.
Depending on the stage at diagnosis, luminal B breast cancer may be curable, meaning it can go into remission with treatment. But it can also come back.
The risk of cancer recurrence varies depending on several factors like stage and growth rate. For this reason, your provider will continue to monitor your health, even if you’re in remission. They may also recommend additional therapies after surgery and radiation to reduce your risk of cancer returning.
The five-year survival rate for HR+/HER2+ (hormone receptor-positive/human epidural growth factor receptor 2-positive) breast cancer is 91.5%. That means that over 91% of people with this type of cancer are alive five years after their diagnosis.
Advertisement
The five-year survival rate for HR+/HER2- (hormone receptor-positive/human epidural growth factor receptor 2-negative) breast cancer is 95.1%.
It’s important to understand that survival rates are only estimates. They can’t tell you how long you’ll live or how you’ll respond to a certain treatment. If you want to know what survival rates mean for you, talk to your healthcare provider.
Living with luminal B breast cancer can be exhausting. You might feel OK one day and completely overwhelmed the next. It’s important to take good care of yourself throughout your diagnosis and treatment. Consider these suggestions:
You should tell your healthcare provider any time you develop new or changing symptoms. This includes pain or weakness in another part of your body.
Advertisement
If you have luminal B breast cancer, here are some questions you might want to ask your healthcare provider:
“You have cancer” might be the scariest words you’ll ever hear. You’ll likely have a lot of questions as you adjust to change and uncertainty. Lean on your healthcare team. They’re here to help. With luminal B breast cancer, they can personalize your care based on the molecular structure of your cells. To learn more about what your lab results mean for your treatment plan, talk to your healthcare provider.
Last reviewed on 10/22/2024.
Learn more about the Health Library and our editorial process.